IPLATO Mobile Services Reach 1 Million Patients In The UK

Main Category: IT / Internet / E-mail
Article Date: 14 Dec 2007 - 1:00 PST

Current ratings for:
'IPLATO Mobile Services Reach 1 Million Patients In The UK'

Patient / Public:5 stars

5 (2 votes)

Healthcare Prof:not yet rated


iPLATO Healthcare, leader in mobile health promotion, revealed that coverage of their Patient Care Messaging services has risen to over a million GP patients. Fuelling this growth has been the ground breaking platform combined with the company's unique service offering and expertise which allows its NHS partners to dramatically improve patient access and deliver powerful health promotion campaigns. With continued focus on delivering improved health of patient and populations in partnership with primary care organisations iPLATO expects reaching 10 million patients within the next 24 months.

To accelerate the growth of the company's service offering beyond text and voice messaging it has launched a mobile health portal framework targeted at access improvement, health promotion and support to people with long term conditions. iPLATO's NHS partners will start benefiting from the mobile portal framework and richer mobile health applications in the New Year.

Tobias Alpsten, Managing Director of iPLATO, said: "Reaching our first million patients is only a step on the way. There are more than 3 billion mobile handsets in the world today, each owned by a person for whom health is important, so there is a lot of room for growth. In addition to our in-house research and development efforts we actively seek partners with specific clinical skills to add to our overall service offering. We owe our healthcare provider partners and patients best-of-breed services. We expect many of these new, exiting, services to be delivered in partnership with universities, hospitals, clinical experts and other innovation companies across the world. We are especially interested in mobile applications that support people with long term conditions such as hypertension, diabetes, asthma, depression and coronary heart disease."

About iPLATO

iPLATO is a privately owned innovation company head quartered in London. Over the last four years the company has invested substantial resources towards overcoming the barriers to entry of the United Kingdom healthcare market and building a mobile healthcare business. In 2003, iPLATO was awarded a SMART Feasibility Grant by the Department of Trade & Industry to study the feasibility of a national implementation of a system to remind outpatients about scheduled appointments using text messaging technology.

Since completing the study, the company has built a promising business around its flagship service - Patient Care Messaging. The European Venture Contest, organised by the European Commission, recently recognised iPLATO as one of the top ten early stage technology ventures ready to "reshape their industry and to conquer the global market". The company featured on the Red Herring Europe Top 200 of companies to watch in 2006.

http://www.iplato.net

Article adapted by Medical News Today from original press release.
Visit our it / internet / e-mail section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
iPLATO. "IPLATO Mobile Services Reach 1 Million Patients In The UK." Medical News Today. MediLexicon, Intl., 14 Dec. 2007. Web.
26 May. 2012. <http://www.medicalnewstoday.com/releases/91716.php>

APA
iPLATO. (2007, December 14). "IPLATO Mobile Services Reach 1 Million Patients In The UK." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/91716.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'IPLATO Mobile Services Reach 1 Million Patients In The UK'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


IT / Internet / E-mail

Most Popular Articles



Follow Our IT News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our IT / Internet / E-mail Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »